Intensive Hemodialysis and Potential Risks with Increasing Treatment

Slides:

Advertisements

Similar presentations

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Advertisements

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):

Home care assistance and the utilization of peritoneal dialysis

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Intensive Hemodialysis, Treatment Complications and Tolerability

Intensive Hemodialysis, Treatment Complications and Tolerability

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Intensive Hemodialysis and Health-related Quality of Life

CHOICE: Relative risk of death on peritoneal dialysis vs hemodialysis

Intensive Hemodialysis and Health-related Quality of Life

Hypertension in Dialysis Patients

Mae Thamer, Timmy C. Lee, Haimanot Wasse, Marc H

Intensive Hemodialysis and Potential Risks with Increasing Treatment

Hemodialysis Vascular Access Creation in Patients Switching From Peritoneal Dialysis to Hemodialysis: A Population-Based Retrospective Cohort Ahmed A.

Adjusted relative mortality risk

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

New options for the anemia of chronic kidney disease

Change in mean LVMI with erythropoietin alpha hemoglobin maintenance treatment and control/delayed treatment from baseline to 24 months End point Hemoglobin.

In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’ Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.

Hypertension in Dialysis Patients

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson, MD, MPH, Weiling Wang,

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.

Erratum Regarding “Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials” (Am.

Cardiovascular Disease and CKD: Core Curriculum 2010

Intensive Hemodialysis and Health-Related Quality of Life

The risk of hospitalization and modality failure with home dialysis

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients James B. Wetmore, Suying Li, Julia.

Chapter 3: Management of progression and complications of CKD

Erratum Regarding “Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients” [Am J Kidney Dis 2009; 54: ]

Erratum Regarding “Ultrasound Monitoring to Detect Access Stenosis in Hemodialysis Patients: A Systematic Review” (Am J Kidney Dis. 2008;51(4): )

Volume 82, Issue 1, Pages (July 2012)

Volume 80, Issue 10, Pages (November 2011)

Volume 63, Issue 2, Pages (February 2003)

Volume 80, Issue 9, Pages (November 2011)

Recasting Kidney Failure as Cardiovascular Disease

Michael Copland, MD, Paul Komenda, MD, Eric D

Volume 77, Issue 7, Pages (April 2010)

Volume 91, Issue 5, Pages (May 2017)

This Month in AJKD American Journal of Kidney Diseases

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

Acute myocardial infarction in patients with end-stage renal disease

Body size and outcomes on peritoneal dialysis in the United States

Volume 64, Issue 3, Pages (September 2003)

Jeffrey Perl, MD, FRCP(C), Christopher T. Chan, MD, FRCP(C)

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Intensive Hemodialysis and Potential Risks With Increasing Treatment

George L. Bakris, MD, John M. Burkart, MD, Eric D

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Better Management of Volume with Intensive Hemodialysis

Volume 57, Issue 4, Pages (April 2000)

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

Volume 58, Issue 6, Pages (December 2000)

Executive summary American Journal of Kidney Diseases

American Journal of Kidney Diseases

Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.

Volume 86, Issue 2, Pages (August 2014)

Volume 61, Issue 2, Pages (February 2002)

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Stephen Pastan, J. Michael Soucie, William M. McClellan

Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.

Catheter Type, Placement, and Insertion Techniques for Preventing Catheter-Related Infections in Maintenance Peritoneal Dialysis Patients: Summary of.

Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.

Presentation transcript:

Intensive Hemodialysis and Potential Risks with Increasing Treatment Kraus MA, Kansal S, Copland M, Komenda P, Weinhandl ED, Bakris GL, Chan CT, Fluck RJ, Burkhart JM. Intensive Hemodialysis and Potential Risks with Increasing Treatment. American Journal of Kidney Diseases, Volume 68, Issue 5, S51 - S58. AdvancingDialysis.org

Infection appears to be more likely with intensive hemodialysis, although the relative importance of frequency versus setting (in-center versus home) merits further investigation.1,2,3,4,5 Chapter 6, Figure 1:6 Relative hazards of cause-specific infection-related hospitalization for short daily hemodialysis versus conventional in-center hemodialysis1 and versus peritoneal dialysis.2 Solid lines represent 95% confidence intervals around estimated hazard ratios (solid dots).Abbreviations: CIHD, in-center hemodialysis; PD, peritoneal dialysis; SDHD, short daily hemodialysis. 1Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis Off J Natl Kidney Found. 2015;65(1):98-108. doi:10.1053/j.ajkd.2014.06.015. 2Weinhandl ED, Gilbertson DT, Collins AJ. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study. Am J Kidney Dis Off J Natl Kidney Found. 2016;67(1):98-110. doi:10.1053/j.ajkd.2015.07.014. 3FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300. doi:10.1056/NEJMoa1001593. 4Rocco MV, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080-1091. doi:10.1038/ki.2011.213. 5Spry LA, Burkart JM, Holcroft C, Mortier L, Glickman JD. Survey of home hemodialysis patients and nursing staff regarding vascular access use and care. Hemodial Int Int Symp Home Hemodial. 2015;19(2):225-234. doi:10.1111/hdi.12211. 6Kraus, M.A., Kansal, S., Copland, M. et al, Intensive hemodialysis and potential risks with increasing treatment. Am J Kidney Dis. 2016;68:S51–S58. AdvancingDialysis.org